Arteris Insider Kunkel Ups Stake to 66,322 Shares in Routine Grant

Rhea-AI Filing Summary

Arteris, Inc. (AIP) – Form 4 insider filing

Director Joachim Kunkel reported the acquisition of 1,727 fully-vested restricted shares of Arteris common stock on 07/05/2025. The shares represent board retainer fees that Mr. Kunkel chose to receive in stock rather than cash; the filing states the director also elected to defer receipt of these shares. The transaction was recorded at a price of $0.00 because it is compensation-related, not an open-market purchase. Following the award, Mr. Kunkel’s direct ownership increases to 66,322 shares. No derivative security activity was reported.

The filing indicates Mr. Kunkel remains classified as a Director and files individually. No amendments or additional reporting persons are noted.

While the award is modest in size, insider share accumulation—especially when taken in lieu of cash—may signal greater alignment with shareholder interests. However, because it is routine compensation rather than a discretionary market purchase, the market impact is likely limited.

Positive

• Director increased ownership by 1,727 shares, signalling continued equity alignment with shareholders.
• Shares accepted in lieu of cash compensation, indicating confidence in company value and conserving corporate cash.

Negative

• Acquisition priced at $0.00; therefore, it does not represent an out-of-pocket investment by the insider.
• Small transaction size relative to total shares outstanding, implying minimal effect on insider-ownership percentage and market perception.

Insights

Financial Analyst

TL;DR: Routine director stock grant; minor positive alignment, negligible valuation impact.

This Form 4 details a standard equity retainer of 1,727 shares (~0.2% of Mr. Kunkel’s holdings) taken instead of cash. The zero-dollar price confirms it is a compensation grant, not a sentiment-driven buy. His total stake now stands at 66,322 shares, a small fraction of Arteris’ outstanding float, so dilution is immaterial. Investors may view the choice to accept stock as marginally positive for governance alignment, but the transaction size and non-cash nature suggest neutral overall impact on near-term valuation or trading dynamics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kunkel Joachim

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/05/2025		A		1,727(1)(2)	A	$0.00	66,322	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.

2. The Reporting Person elected to defer the receipt of shares.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Kunkel Joachim	07/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Arteris (AIP) shares did Director Joachim Kunkel acquire?

He acquired 1,727 fully-vested restricted shares on 07/05/2025.

Was the insider purchase an open-market buy?

No. The shares were board retainer fees taken in stock form at a stated price of $0.00.

What is Kunkel’s total shareholding after the transaction?

Following the award, he directly owns 66,322 AIP shares.

Does the filing include any derivative securities activity?

No derivative securities were acquired or disposed of in this Form 4.

Is this Form 4 filing likely to impact AIP’s stock price?

Impact is likely minimal due to the small size and compensation nature of the grant.